JCI-accredited · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
General Health

Doptelet: A Complete Medical Overview

9 min read Published August 19, 2026
Medical professionals and a patient in a hospital corridor at Acibadem Hospitals Group.
Quick answer

Doptelet is an oral thrombopoietin receptor agonist that helps the body produce more platelets. It is approved for specific causes of low platelet counts and is not suitable for every type of thrombocytopenia.

Key Takeaways

  • Doptelet is an oral thrombopoietin receptor agonist that helps the body produce more platelets.
  • It is approved for specific causes of low platelet counts and is not suitable for every type of thrombocytopenia.
  • Treatment goals are to reduce bleeding risk and support necessary procedures, not to make platelet counts higher than normal.
  • Blood tests are needed to monitor platelet response and help guide treatment safely.
  • Blood clots are an important potential risk, especially for people with existing clotting risk factors.

Medically reviewed by the Acıbadem International Medical Board — August 22, 2026

Dr. Bahadır Kaynarkaya, MD Dr. Mohamed Al-Qadi, MD Dr. Şule Eren, MD Dr. Tarek Arafat, MD

Doptelet is the brand name for avatrombopag, a prescription medicine used to increase platelet counts in selected adults with thrombocytopenia. It may be used before an invasive procedure in people with chronic liver disease or as ongoing treatment for chronic immune thrombocytopenia when other treatments have not worked sufficiently.

What Is Doptelet?

Doptelet is a prescription medicine containing avatrombopag. It belongs to a group of medicines called thrombopoietin receptor agonists. These medicines stimulate the bone marrow, the body’s blood-cell-producing tissue, to make more platelets.

Platelets are small blood components that help form clots and limit bleeding after an injury. A low platelet count is called thrombocytopenia. Depending on its cause and severity, thrombocytopenia may lead to easy bruising, pinpoint red or purple spots on the skin, nosebleeds, bleeding gums, or heavier menstrual bleeding. Some people have no noticeable symptoms and learn about a low count through a blood test.

Doptelet is used in particular clinical situations in adults. It can help raise platelet counts in people with chronic liver disease who are scheduled for an invasive procedure, and it can be used for chronic immune thrombocytopenia (ITP) when a previous treatment has not provided an adequate response. It is prescribed and monitored by a clinician familiar with blood disorders, liver disease, or both.

How Doptelet Works and What It Is Used For

How Doptelet Works and What It Is Used For — doptelet

Avatrombopag works by activating the thrombopoietin receptor, which is involved in platelet production. Thrombopoietin is a naturally occurring signal in the body that tells the bone marrow to produce platelets. Doptelet supports this signaling pathway, helping increase the number of circulating platelets over time.

For adults with chronic liver disease and thrombocytopenia, Doptelet may be prescribed before a planned procedure that could cause bleeding. Its purpose is to increase platelet levels enough to reduce the need for a platelet transfusion in appropriate patients. It is taken for a short, planned treatment course before the procedure, according to the clinician’s instructions.

For adults with chronic ITP, the immune system mistakenly targets and removes platelets. Doptelet may be considered when other treatments have not achieved a sufficient platelet response. In this setting, it may be used as longer-term treatment, with regular blood tests and treatment adjustments based on platelet counts. It is not intended to restore platelet counts to an unnecessarily high or “normal” level.

Doptelet does not treat every cause of thrombocytopenia. Low platelet counts can result from infections, medicines, bone marrow disorders, cancer treatments, nutritional deficiencies, autoimmune conditions, alcohol use, an enlarged spleen, or liver disease. Identifying the underlying cause remains an essential part of care.

Who May Be Considered for Treatment

Doctor consulting with elderly patient in a medical office.

A doctor may consider Doptelet after reviewing the cause of the low platelet count, the person’s medical history, current medicines, planned procedures, and risk of bleeding or clotting. A complete blood count, including platelet count, is central to this assessment. Additional testing may be needed when the cause of thrombocytopenia is unclear.

For chronic liver disease, the decision is linked to the planned procedure and its expected bleeding risk. The timing of treatment is carefully coordinated with the procedural team. Doptelet is not a general treatment for all liver-related health concerns and does not replace treatment for the underlying liver condition.

For chronic ITP, clinicians consider factors such as bleeding symptoms, platelet trends, lifestyle, other health conditions, and prior therapies. Some people with ITP and mild symptoms may only need observation, while others may require treatment to reduce bleeding risk. The best approach is individualized.

People should tell their doctor if they have ever had a blood clot, stroke, heart attack, circulation problem, inherited clotting disorder, or cancer. These conditions do not automatically rule out treatment, but they can affect whether Doptelet is appropriate and how closely a person should be monitored.

Taking Doptelet Safely

Doptelet is taken by mouth with food. The exact schedule differs according to why it is being prescribed. For a procedure related to chronic liver disease, treatment is generally started in advance and taken for a limited number of days. For chronic ITP, the schedule may be adjusted over time according to platelet test results.

It is important to take the medicine exactly as prescribed and not to change the schedule without medical advice. A person should not take extra tablets after a missed dose unless their prescribing clinician specifically instructs them to do so. If a dose is missed, the patient should contact the prescribing team or follow the instructions provided with the medicine.

Regular platelet monitoring helps clinicians assess whether the medicine is working and whether the treatment plan should change. In chronic ITP, blood counts are usually checked more often when treatment begins or changes, then at intervals once the platelet count is stable. Monitoring may continue for a period after treatment is stopped because platelet counts can fall again.

A complete medication review is also important. Some medicines can change how avatrombopag is processed in the body, including certain medicines that affect liver enzymes. Patients should provide a full list of prescription medicines, non-prescription products, vitamins, supplements, and herbal remedies before starting treatment.

Possible Side Effects and Important Risks

Like all medicines, Doptelet can cause side effects, although not everyone experiences them. Potential side effects vary depending on the condition being treated and a person’s other health concerns. Commonly reported effects may include headache, tiredness, nausea, fever, abdominal discomfort, swelling, cold-like symptoms, or changes seen on blood tests.

A key safety concern is the possibility of blood clots, also called thrombotic or thromboembolic events. Raising platelet counts may contribute to clotting risk in some people, particularly those who already have risk factors. A clot can occur in a leg, lung, brain, heart, or blood vessels associated with the liver. The prescribing clinician weighs this risk against the expected benefit of treatment.

Patients should seek urgent medical attention for symptoms that could suggest a serious blood clot, such as new chest pain, sudden shortness of breath, coughing up blood, swelling or pain in one leg, sudden weakness or numbness on one side of the body, trouble speaking, severe sudden headache, or vision changes. These symptoms can have different causes but should always be assessed promptly.

Allergic reactions are uncommon but require immediate care. Signs can include hives, facial or throat swelling, wheezing, or difficulty breathing. Patients should also report unusual bleeding, persistent new symptoms, or side effects that interfere with daily life. The doctor can advise whether monitoring, supportive care, or a change in treatment is needed.

Pregnancy, Breastfeeding and Everyday Considerations

Anyone who is pregnant, planning pregnancy, or breastfeeding should discuss Doptelet with their doctor. The clinician will consider the available safety information, the reason treatment is needed, and the potential risks of untreated thrombocytopenia. Pregnancy can itself affect platelet counts, so specialist input may be particularly helpful.

Patients should not assume that over-the-counter pain relievers, supplements, or herbal products are harmless when platelet counts are low. Some products may increase bleeding risk or interact with prescribed medicines. A doctor or pharmacist can recommend options that fit the individual’s health circumstances.

While receiving treatment for thrombocytopenia, practical measures can help reduce injury-related bleeding. These may include using a soft toothbrush, taking care with shaving, avoiding contact sports when platelet counts are very low, and limiting activities with a high risk of falls or trauma. The appropriate precautions depend on the platelet count, symptoms, and advice from the care team.

Healthy daily habits, including balanced nutrition, limiting alcohol where medically advised, and attending scheduled blood tests, can support overall care. However, diet or supplements alone should not be relied upon to treat a medically significant low platelet count without guidance from a qualified clinician.

When to Seek Medical Care

A person taking Doptelet should contact their healthcare team promptly if they develop worsening bruising, frequent nosebleeds, bleeding gums, blood in urine, black or bloody stools, unusually heavy menstrual bleeding, or bleeding that is difficult to stop. These signs do not always indicate a medical emergency, but they require timely assessment.

Emergency medical care is needed for severe bleeding, vomiting blood, coughing up blood, a serious head injury, fainting, confusion, or signs of a possible blood clot such as chest pain, sudden breathlessness, one-sided weakness, difficulty speaking, or painful swelling in one leg.

Follow-up appointments are an important part of safe treatment. They allow the clinician to review platelet results, symptoms, medication interactions, and the ongoing need for Doptelet. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat blood and liver-related conditions for international patients, with care plans guided by individual clinical needs.

Frequently asked questions

Is Doptelet a blood thinner?

No. Doptelet is not a blood thinner. It is a medicine that stimulates platelet production and is used to raise low platelet counts in specific situations. Because it can increase platelet levels, it may also increase the risk of blood clots in some people.

How quickly does Doptelet increase platelet counts?

The platelet response is not immediate and depends on the reason for treatment, the starting platelet count, and individual response. For procedures in people with chronic liver disease, it is prescribed on a planned schedule before the procedure. For chronic ITP, blood tests guide whether the treatment is achieving an appropriate response.

Can Doptelet cure immune thrombocytopenia?

Doptelet can help raise platelet counts in chronic ITP, but it does not cure the underlying immune condition. Some people need ongoing treatment, while others may use different treatments over time. A hematology specialist can help determine the most suitable long-term plan.

Can Doptelet be used for any low platelet count?

No. Doptelet is approved for particular adult patients with thrombocytopenia related to chronic liver disease before a planned procedure or chronic ITP after insufficient response to previous treatment. The cause of low platelets should be evaluated before treatment because management differs between conditions.

What should a patient tell the doctor before taking Doptelet?

Patients should share their full medical history, especially any previous blood clots, heart or circulation conditions, liver disease, cancer, pregnancy plans, and bleeding problems. They should also provide a complete list of medicines, supplements, and herbal products. This helps the clinician assess interactions and individual safety risks.

What happens if Doptelet is stopped?

After Doptelet is stopped, platelet counts may decrease again, particularly in people taking it for chronic ITP. The healthcare team may continue blood tests for a period after discontinuation and will advise on signs of bleeding that need prompt attention. Patients should not stop the medicine without discussing it with their prescribing clinician.

References

  • U.S. Food and Drug Administration
  • European Medicines Agency
  • American Society of Hematology
  • National Heart, Lung, and Blood Institute
  • MedlinePlus

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Add Acıbadem on Google

Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.

Share this page
Was this content helpful?
Your feedback helps us improve.
Dr. Lanya Qadir Khayat
Dr. Lanya Qadir Khayat, MD
Author
View profile →
Keep Reading

More from the Health Library

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.